Clinical Trials for Genetix Biotherapeutics

Explore 8 clinical trials worldwide

Showing 1-8 of 8 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Genetix Biotherapeutics

Clinical Trials (8)

A Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcel

120 participants

Started: Mar 27, 2024 · Completed: Dec 30, 2047

1 condition2 sponsors3 locations

A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel

150 participants

Started: Jan 23, 2024 · Completed: Dec 31, 2043

1 condition2 sponsors6 locations

A Gene Transfer Study Inducing Fetal Hemoglobin in Sickle Cell Disease (GRASP, BMT CTN 2001)

PHASE2Active, not recruiting

25 participants

Started: Jul 12, 2022 · Completed: Jul 31, 2027

1 condition5 sponsors9 locations

Long-term Follow-up of Subjects with Sickle Cell Disease Treated with Ex Vivo Gene Therapy

N/AEnrolling by invitation

85 participants

Started: Oct 21, 2020 · Completed: Jan 31, 2038

1 condition1 sponsor16 locations

A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Disease

PHASE3Active, not recruiting

35 participants

Started: Feb 14, 2020 · Completed: Nov 30, 2027

1 condition1 sponsor9 locations

Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant

EARLY_PHASE1Active, not recruiting

18 participants

Started: May 31, 2019 · Completed: May 15, 2025

2 conditions2 sponsors2 locations

Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product

N/AActive, not recruiting

64 participants

Started: Jan 22, 2016 · Completed: Aug 31, 2038

3 conditions1 sponsor13 locations

Long-term Follow-up of Subjects With Transfusion-Dependent β-Thalassemia (TDT) Treated With Ex Vivo Gene Therapy

N/AActive, not recruiting

66 participants

Started: Jan 31, 2014 · Completed: Nov 30, 2035

1 condition1 sponsor15 locations